Skip to main content

Table 1 Characteristics of the patients with chronic necrotizing pulmonary aspergillosis

From: Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis

Patient Sex Age Disease All antifungal medication On antifungals when tested Biopsy or BAL1 Serology2
#1 Female 61 Sarcoidosis ITR, VOR No Pos. Neg.
#2 Male 52 AML ITR, VOR No Pos. Pos.
#3 Male 53 Sarcoidosis ITR, VOR No Pos. Pos.
#4 Female 63 Tbc ITR, VOR Yes Neg. Pos.
#5 Male 71 ND VOR Yes Neg. Pos.
#6 Male 78 ND None No Neg. Pos.
#7 Male 78 RA None No Pos. Neg.
#8 Male 63 ND VOR No Pos. Pos.
#9 Male 57 Emphysema FLU, AMB, VOR, CAS Yes Pos. Pos.
#10 Male 65 Sarcoidosis CAS, VOR No Pos. Neg.
  1. AML, treated for acute myelogenic leukemia ten years ago; Tbc, previous pulmonary tuberculosis; ND, no primary pulmonary disorders or pre-disposing immunodeficiency were detected; RA, rheumatoid arthritis; ITR, itraconazole; VOR, voriconazole; FLU, fluconazole; AMB, amphotericin B; CAS, caspofungin.
  2. 1 Culture or through direct microscopy.
  3. 2 At time of sampling.